Stay updated on Autologous TIL MDA-TIL in Recurrent Cancer Clinical Trial
Sign up to get notified when there's something new on the Autologous TIL MDA-TIL in Recurrent Cancer Clinical Trial page.

Latest updates to the Autologous TIL MDA-TIL in Recurrent Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange Detected- Version updated from v3.4.1 to v3.4.2. No user-facing content or functionality changes observed.SummaryDifference0.0%

- Check18 days agoChange DetectedUpdated site revision from v3.4.0 to v3.4.1. This appears to be a minor internal update with no visible changes to the study details or navigation.SummaryDifference0.0%

- Check33 days agoChange DetectedUI and metadata label updates include glossary toggles (Show glossary / Hide glossary) and revised fields (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0), with older labels replaced (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check40 days agoChange DetectedThe page now displays Revision: v3.3.4 (replacing v3.3.3), a minor site update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check69 days agoChange DetectedThe page now includes a Locations section listing Texas as a study site (Houston, TX); the HHS Vulnerability Disclosure link and the Texas Locations header were removed.SummaryDifference0.2%

- Check91 days agoChange DetectedThe Publications section now notes that PubMed auto-fills publications and may not be about the study, and the revision is updated to v3.3.2; the prior PubMed disclaimer and v3.2.0 revision were removed.SummaryDifference0.1%

Stay in the know with updates to Autologous TIL MDA-TIL in Recurrent Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Autologous TIL MDA-TIL in Recurrent Cancer Clinical Trial page.